Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa
- 1 March 2009
- Vol. 27 (14) , 2023-2029
- https://doi.org/10.1016/j.vaccine.2008.11.092
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- A Phase II, Randomized Study on an Investigational DTPw-HBV/Hib-MenAC Conjugate Vaccine Administered to Infants in Northern GhanaPLOS ONE, 2008
- Emergence of W135 meningococcal meningitis in GhanaTropical Medicine & International Health, 2005
- Validation of Serological Correlate of Protection for Meningococcal C Conjugate Vaccine by Using Efficacy Estimates from Postlicensure Surveillance in EnglandClinical and Vaccine Immunology, 2003
- Meningitis seasonal pattern in Africa and detection of epidemics: a retrospective study in Niger, 1990–1998Transactions of the Royal Society of Tropical Medicine and Hygiene, 2000
- Meningococcal meningitis in AfricaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1999
- Group A meningococcal carriage in travelers returning from Saudi ArabiaJAMA, 1988
- AGE-SPECIFIC DIFFERENCES IN DURATION OF CLINICAL PROTECTION AFTER VACCINATION WITH MENINGOCOCCAL POLYSACCHARIDE A VACCINEThe Lancet, 1985
- Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of AgeNew England Journal of Medicine, 1977
- HUMAN IMMUNITY TO THE MENINGOCOCCUSThe Journal of Experimental Medicine, 1969
- HUMAN IMMUNITY TO THE MENINGOCOCCUSThe Journal of Experimental Medicine, 1969